We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Combining Multiple Laboratory Techniques Provides Deeper Insights into Deadly Brain Tumors

By LabMedica International staff writers
Posted on 15 May 2025

Glioblastoma (GBM) is a highly aggressive primary brain cancer that currently has limited effective treatments. More...

Stereotactic needle biopsies are commonly employed for diagnosis; however, their use is restricted as physicians typically limit the collection of small tumor samples due to the invasive nature of the procedure, which requires sedation with anesthesia. Tumor samples are usually obtained at the start of treatment and, occasionally, at the end. In a groundbreaking study, a team of researchers has shown that doctors can gather extensive information about a patient’s cancer by applying various laboratory techniques to analyze tumor tissue obtained from needle biopsies of glioblastoma. This work, published in Nature Communications, could also have significant implications for diagnosing and studying other types of cancer.

In the study, clinicians from Johns Hopkins Kimmel Cancer Center (Baltimore, MD, USA) and four other institutions injected a virus designed to target and kill glioblastoma cells directly into the tumor. During the same procedure, surgeons collected tumor tissue samples, which were then analyzed using multiple advanced laboratory techniques, including single-cell RNA sequencing, transcriptomics, metabolomics, proteomics, and immune profiling. These techniques allowed the researchers to demonstrate that even small samples of tumor tissue could provide valuable insights into the tumor's biological characteristics, immune interactions, and molecular pathways. Additionally, the study found that the tissue could be grafted onto a mouse model for further examination and analysis.

“This is a concept that expands beyond just brain cancers,” said study co-author Chetan Bettegowda, M.D., Ph.D. “Whenever people do needle biopsies, it has been just sufficient to study if the tissue is cancerous, what type and maybe some very simple molecular characterization. This brings tissue analysis to the modern age. ... Historically [oncologists] haven’t done repeat biopsies because we felt, ‘Oh, what are we going to get that we don’t already know from the original diagnosis?’ It turns out there’s quite a bit to be learned.”

Related Links:
Johns Hopkins Kimmel Cancer Center


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.